← SynDRA
BMS-191011
SynDRA canonical compound SYN0049591 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | KCNMA1 |
|---|
| Mechanism of action | Potassium channel activator |
|---|
All known targets
Mechanisms of action (all sources)
- Potassium channel activator
- KCNMA1 MODULATOR
Cross-references
Synonyms
- Bms-a
- LW7MXS978N
- BMS191011
- RefChem:120701
- DTXCID1096632
- MFCD09753285
- UNII-LW7MXS978N
- C16H10ClF3N2O3
- orb1299753
- SCHEMBL5752911
- SCHEMBL29572389
- CHEBI:93672
- GTPL14022
- GLXC-02834
- HMS3269L09
- HMS3413P11
- HMS3677P11
- EX-A4811
- HB1043
- AKOS015998625
- NCGC00167822-01
- AC-36591
- AS-16423
- SY336000
- DB-356477
- HY-108593
- CS-0029268
- T7512
- W18687
- F797003
- BRD-K95609758-001-01-1
- BRD-K95609758-001-03-7
Look up BMS-191011 in the interactive SynDRA portal →